{"entity":{"id":"nct06391892","kind":"trial","name":"Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery","aka":["LIQUIPANC"],"tldr":"A phase 3 trial in pancreatic cancer, run by Elisabethinen Hospital, now recruiting.","summary":"Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery is a phase 3, interventional study registered as NCT06391892 by Elisabethinen Hospital, with a registry enrolment figure of 100 participants, started 2024-01-11 and due to reach its primary completion in 2025-12-31. Interventions recorded: Neoadjuvant chemotherapy instead of upfront surgery; Upfront surgery. Conditions listed: Pancreatic Cancer; Circulating Tumor Cell; Predictive Cancer Model. Primary outcome: DFS. Pancreatic eligibility wording from the registry: \"* localized pancreatic cancer to go for upfront surgery\". Sites: Austria. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06391892","url":"https://clinicaltrials.gov/study/NCT06391892"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["resectable-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06391892","phase":"3","setting":"Liquid Biopsy Guided Treatment in Localized Pancreatic Cancer (LIQUIPANC): Circulating Tumor DNA (ctDNA) as Precision Medicine Tool for Stratification of Neoadjuvant Chemotherapy vs. Upfront Surgery","sponsor":"Elisabethinen Hospital","participation":[{"nct":"NCT06391892","source":"https://clinicaltrials.gov/study/NCT06391892","fetchedAt":"2026-10-07T16:54:38.047Z","studySha256":"38f071072a54b63200bec53eac4d6d2eeb32922747aa5240894e45078b2f713d","overallStatus":"RECRUITING","lastUpdatePosted":"2024-04-30","leadSponsor":"Elisabethinen Hospital","collaboratorCount":1,"minimumAge":"18 Years","maximumAge":"99 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":100,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["Austria"]}],"started":"2024-01-11","startedType":"actual","enrolled":100,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06391892/","neighbours":{"cancer":[{"id":"resectable-pdac","kind":"cancer","name":"Resectable pancreatic ductal adenocarcinoma","route":"/cancers/resectable-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}